These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Treatment results and complications of the mega-volt therapy in cervix uteri carcinomas]. Frischbier HJ, Lohbeck HU. Strahlentherapie; 1970 Jul; 140(1):13-9. PubMed ID: 4992087 [No Abstract] [Full Text] [Related]
6. [Electron therapy in breast cancers]. Bataini JP, Ennuyer A. J Radiol Electrol Med Nucl; 1971 Oct; 52(10):608-10. PubMed ID: 5001270 [No Abstract] [Full Text] [Related]
7. Comparison of conventional and supervoltage radiation in the management of cancer of the cervix. Analysis of survival rates and complications. Mercado R, Sala JM. Radiology; 1968 May; 90(5):967-70. PubMed ID: 4967448 [No Abstract] [Full Text] [Related]
10. The importance of urologic study in choice of treatment and in prognostic evaluation of the advanced uterine cervix cancer. Siracká E, Marton I. Neoplasma; 1967 May; 14(1):105-8. PubMed ID: 4961987 [No Abstract] [Full Text] [Related]
12. [The influence of fever during radiotherapy on the 5-year survival numbers of cervix carcinoma 1954-1961]. Weishaar J, von Freyberg I. Strahlentherapie; 1969 Sep; 138(3):323-7. PubMed ID: 4981654 [No Abstract] [Full Text] [Related]
13. [Cancers of the uterine cervix from 1960 to 69, treated at the François Baclesse Center, Caen]. Roussel A, Abbatucci JS, Alperine G, Quint R, Brune D. J Radiol Electrol Med Nucl; 1972 Mar; 53(3):213-9. PubMed ID: 5051024 [No Abstract] [Full Text] [Related]
15. Supervoltage radiation treatment in advanced cancer of the uterine cervix. A preliminary report. Allt WE. Can Med Assoc J; 1969 May 03; 100(17):792-7. PubMed ID: 4976329 [No Abstract] [Full Text] [Related]
16. The management of recurrences of malignant tumors of the uterine cervix by 42 MeV betatron. Coucourde F, Maestro A. Radiol Clin Biol; 1970 May 03; 39(5):407-18. PubMed ID: 4990180 [No Abstract] [Full Text] [Related]
19. [Evaluation of the therapeutic methods in the treatment of female genital carcinoma with special regard to vulva- and cervix carcinoma]. De la Osa Garces LL. Osterr Z Erforsch Bekampf Krebskr; 1972 May 03; 27(4):221-7. PubMed ID: 4628042 [No Abstract] [Full Text] [Related]